BIOGEN
Spinraza
Resolved
102days ago
Approval decision · Mar 27, 2026
What's at stake
A final FDA approval decision on Spinraza for its lead indication is expected Mar 27, 2026.
Primary source
· openFDA
verified 15h ago
“FDA approved Spinraza (NDA209531) — sponsor BIOGEN; efficacy supplement (Efficacy); FDA action date 2026-03-27.”